This listing contains COVID-19 projections for countries in the European Economic Area (EEA). Projections are at the subnational level for three locations in the EEA: Germany, Italy and Spain.
This offering is exclusively for use by non-commercial organizations.
The Institute for Health Metrics and Evaluation (IHME) at the University of Washington is regularly updating data on the current and projected spread of coronovirus disease 2019 (COVID-19), and on related on hospital resource needs versus capacity. The projections are designed to assist all those wishing to track the progression of this disease; the analysis is designed especially to help decision-makers prepare for and respond to a surge in cases and deaths by projecting, in addition to daily death counts, peak needs against peak capacity for, bed use, ICU use, and ventilator use. As the spread of the virus is rapidly changing, we are gathering new data, updating our models and producing new projections daily for as many locations as possible. This listing contains COVID-19 projections for countries in the European Economic Area (EEA). Projections are at the subnational level for three locations in the EEA: Germany, Italy and Spain.
Data sets:
Data Sets contain findings generated by IHME’s COVID-19 analytic work. All data within the Data Sets will be population-level and no individual or identifiable health information will be included. This study used data on confirmed COVID-19 deaths by day from the World Health Organization (WHO) and local and national governments, data on hospital capacity and utilization for US states, and observed COVID-19 utilization data from select locations to develop a statistical model forecasting deaths and hospital utilization against capacity over a future 4-month period.
Updates to this data will be made available weekly as a new revision.
Commercial organizations wishing to acquire a license to access and download IHME data, including IHME's COVID-19 projections, should contact services@healthdata.org. IHME data available for use by commercial organizations through a license.
The Global Burden of Disease (GBD) study produces comprehensive and comparable estimates of health conditions around the globe, estimates that are informing real-world policy and implementation. Condition-specific data available for 195 country locations and a further 700 subnational units, including all the states of the US. The full list of GBD locations and conditions available from IHME Client Services.https://docs.google.com/spreadsheets/d/1X0ZnrPnEzrf3wJhMUo1--usXAokEjCmgQwAqxeOXYyk/edit?usp=sharing
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
This listing offers a single pricing dimension: Product Access, measured in units. It is free and grants you access to the COVID-19 European Economic Area (EEA) projections for non-commercial use. There are no tiers, instance sizes, or usage add-ons to compare. You receive product access under one flat, no-cost option. Because the data is intended for non-commercial use, pricing does not scale by locations, conditions, or usage volume.
Top-of-mind questions for buyers
What does one unit of Product Access grant me?
One unit grants you access to the COVID-19 European Economic Area (EEA) projections dataset for non-commercial use. It is not billed by locations, conditions, or usage volume. You subscribe once at no cost to reach the data.
Can I use this dataset for commercial or business purposes?
No. This listing covers non-commercial use only. For commercial use of the underlying health data and tools, you must arrange a separate licensing agreement directly with the vendor.
Will my cost change if I access more of the data over time?
No. Product Access is free and flat. There are no tiers, overage points, or usage thresholds that trigger charges. Accessing more records or projections does not add cost under this non-commercial dimension.
www.ihmeclientservices.org
Helpful?
Vendor refund policy
Refunds are not applicable to this product. For any questions, please contact services@healthdata.org.
How can we make this page better?
Tell us how we can improve this page, or report an issue with this product.
Give us feedbackReport a problem with this product or seller
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA).
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
ZEDOC's COVID-19 Digital Care Pathway is an end-to-end solution for remote monitoring of individuals with suspected for confirmed COVID-19. Automating the collection and analysis of COVID-19 symptoms, the pathway alerts clinical teams of deterioration as it happens.
ZEDOC's COVID-19 Digital Care Pathway is an end-to-end solution for remote monitoring of individuals with suspected for confirmed COVID-19. Automating the collection and analysis of COVID-19 symptoms, the pathway alerts clinical teams of deterioration as it happens.